Showing results (21-30 of 72) with videos related to
Sort By:
Pageof 8
International Journal of Molecular Sciences|April 3, 2020
Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin LymphomaOmbretta Repetto, Valli De Re, Lara Mussolin, et al.Proceedings of the National Academy of Sciences of the United States of America|May 21, 2014
MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomasChristof Schneider, Manu Setty, Antony B Holmes, et al.Blood|December 4, 2013
Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphomaChristine Damm-Welk, Lara Mussolin, Martin Zimmermann, et al.Biomedicines|January 26, 2024
Preliminary Study of the Relationship between Osteopontin and Relapsed Hodgkin's LymphomaValli De Re, Egesta Lopci, Giulia Brisotto, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Minimal disseminated disease in high-risk Burkitt's lymphoma identifies patients with different prognosisLara Mussolin, Marta Pillon, Emanuele S G d'Amore, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhoodLara Mussolin, Marta Pillon, Valentino Conter, et al.Journal of Cancer|February 27, 2016
Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin LymphomaSimona Primerano, Roberta Burnelli, Elisa Carraro, et al.Journal of Pediatric Hematology/Oncology|December 7, 2013
Monoallelic mutations of the perforin gene may represent a predisposing factor to childhood anaplastic large cell lymphomaBenedetta Ciambotti, Lara Mussolin, Emanuele S G d'Amore, et al.Frontiers in Oncology|March 17, 2020
RNY4 in Circulating Exosomes of Patients With Pediatric Anaplastic Large Cell Lymphoma: An Active Player?Federica Lovisa, Piero Di Battista, Enrico Gaffo, et al.Clinical Hematology International|April 18, 2023
Refractory Anaplastic Large Cell Lymphoma Rescued by the Combination of the Second-Generation ALK Inhibitor Brigatinib, High-dose Chemotherapy and Allogeneic Stem Cell Transplantation: A Case Report and Review of the LiteratureGiulia Caddeo, Cristina Tecchio, Matteo Chinello, et al.Pageof 8